International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

(2010) M. J. van den Bent et al.   CLINICAL CANCER RESEARCH

Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma

(2010) Michael Brada et al.   JOURNAL OF CLINICAL ONCOLOGY

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

Optimizing chemotherapy and radiotherapy for anaplastic glioma

(2010) Patrick G. Morris et al.   Nature Reviews Clinical Oncology

Chemotherapy for low-grade gliomas: When? How? How long?

(2010) M. Weller   NEURO-ONCOLOGY

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2

(2010) M. Labussiere et al.   NEUROLOGY

Anaplastic Glioma: How to Prognosticate Outcome and Choose a Treatment Strategy

(2009) Lisa M. DeAngelis   JOURNAL OF CLINICAL ONCOLOGY

MGMTPromoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

(2009) Martin J. van den Bent et al.   JOURNAL OF CLINICAL ONCOLOGY

NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

(2009) Wolfgang Wick et al.   JOURNAL OF CLINICAL ONCOLOGY

Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up

(2009) Linda Douw et al.   LANCET NEUROLOGY

Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial

(2009) Eric L Chang et al.   LANCET ONCOLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131

(2008) Michael A. Vogelbaum et al.   NEURO-ONCOLOGY

Molecular profiling of oligodendrogliomas: Impact on prognosis, treatment, and future directions

(2008) Douglas E. Ney et al.   Current Oncology Reports